Joel Jose

3 days ago | marketscreener.com | Sriparna Roy |Joel Jose

(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges. Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay.

3 days ago | sg.finance.yahoo.com | Sriparna Roy |Joel Jose

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges. Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay.

1 month ago | gurutrade.com | Joel Jose |Nivedita Bhattacharjee

April 7 (Reuters) - Barclays on Monday cut its year-end target for Europe’s STOXX 600 index for the second time in under a month as escalating trade tensions and U.S. tariffs fueled recession fears.